PROCEPT BioRobotics (PRCT) Change in Account Payables (2020 - 2026)

PROCEPT BioRobotics (PRCT) has reported Change in Account Payables for 7 consecutive years, with -$2.9 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Change in Account Payables fell 26.76% year-over-year to -$2.9 million in Q2 2026; TTM through Jun 2026 was $3.8 million, a 190.22% increase from a year earlier, with the FY2025 full-year figure at $6.6 million, up 408.92% from the prior year.
• Change in Account Payables was -$2.9 million for Q2 2026 at PROCEPT BioRobotics, down from $1.5 million in the prior quarter.
• Over five years, Change in Account Payables peaked at $5.9 million in Q4 2025 and troughed at -$5.4 million in Q4 2024.
• A 5-year average of $718222.2 and a median of $396000.0 in 2022 frame the typical range for Change in Account Payables.
• Across the five-year window, Change in Account Payables soared 3722.22% in 2024 and tumbled 754.07% in 2025, its largest moves.
• Over 5 years, Change in Account Payables stood at -$284000.0 in 2022, then jumped by 2169.01% to $5.9 million in 2023, then sank by 191.54% to -$5.4 million in 2024, then surged by 210.3% to $5.9 million in 2025, then slumped by 148.07% to -$2.9 million in 2026.
• The last three Change in Account Payables figures came in at -$2.9 million (Q2 2026), $1.5 million (Q1 2026), and $5.9 million (Q4 2025), per Business Quant data.